Estrogen Protective Against COVID Death; New NAFLD Guidance; At-Home HbA1c Testing

Use of hormone replacement therapy within 6 months of testing positive for COVID-19 was linked with a reduction in infection-related mortality in women. “This study supports the theory that estrogen may offer some protection against severe COVID-19,” said study author Christopher Wilcox, MBBCh, of the University of Southampton in England, in a statement. (Family Practice)

A study from the U.K. found that risk of invasive breast cancer tumors was linked with infertility in men. (Breast Cancer Research)

Co-sponsored by the American Association for the Study of Liver Diseases, the American Association of Clinical Endocrinology (AACE) released clinical practice guidelines for diagnosing and managing nonalcoholic fatty liver disease in both primary care and endocrinology settings. Catch up on coverage from the annual AACE meeting here. (Endocrine Practice)

Following initiation of hormone therapy, a prescribing cascade of antiemetics — most commonly metoclopramide — occurred, according to a cohort study using sequence symmetry analysis. (JAMA Network Open)

Labcorp launched its first ever at-home collection device for HbA1c testing.

Could the herpes virus contribute to the development of prediabetes? (Diabetologia)

A consensus statement in the British Journal of Sports Medicine recommended that people with osteoporosis engage in an exercise routine consisting of strengthening exercises 2 to 3 days per week, as well as brief bursts of moderate-impact activities.

The American Diabetes Association named Charles D. Henderson as their new CEO.